Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

A federal judge has blocked a new bill in Louisiana that would require the Bible's Ten Commandments to be displayed in the ...

Six studies highlight advancements in AI-powered tumor microenvironment profiling, genomic analysis, biomarker identification, immune-related adverse ...

ROSSLARE HARBOUR Ballycogley Players In front of a packed house at the Stella Maris Centre, Kilmore Quay, the curtain came down on what was a hugely successful 1 Act run for the Ballycogley Players.

The Bruins made their annual Halloween hospital visit ... The players spent their time meeting with young fans, signing posters, taking photos and bringing lots of smiles to the hospitals.

The next meeting will take place on this Wednesday 13th November at 7.30pm in Oylegate Community Centre. The annual Christmas raffle will be ... from those who are availing of this facility. In ...